MOXI-BROM Trademark

Trademark Overview

On Tuesday, February 25, 2025, a trademark application was filed for MOXI-BROM with the United States Patent and Trademark Office. The USPTO has given the MOXI-BROM trademark a serial number of 99055944. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, July 25, 2025. This trademark is owned by Harrow IP, LLC. The MOXI-BROM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical compositions for ophthalmological use
moxi-brom

General Information

Serial Number99055944
Word MarkMOXI-BROM
Filing DateTuesday, February 25, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, July 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical compositions for ophthalmological use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 25, 2025
Primary Code005
First Use Anywhere DateThursday, October 10, 2019
First Use In Commerce DateThursday, October 10, 2019

Trademark Owner History

Party NameHarrow IP, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNashville, TN 37205

Trademark Events

Event DateEvent Description
Tuesday, February 25, 2025NEW APPLICATION ENTERED
Tuesday, February 25, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 25, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, April 1, 2025NON-FINAL ACTION WRITTEN
Tuesday, April 1, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 25, 2025ASSIGNED TO EXAMINER
Tuesday, April 1, 2025NON-FINAL ACTION E-MAILED
Thursday, June 26, 2025USE AMENDMENT FILED
Thursday, June 26, 2025TEAS AMENDMENT OF USE RECEIVED
Friday, June 27, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 25, 2025NON-FINAL ACTION WRITTEN
Friday, July 25, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 22, 2025LETTER OF PROTEST EVIDENCE FORWARDED
Monday, September 22, 2025LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Wednesday, October 8, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 8, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 8, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 25, 2025NON-FINAL ACTION E-MAILED
Thursday, June 26, 2025AMENDMENT TO USE PROCESSING COMPLETE
Friday, June 27, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 27, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 10, 2025USE AMENDMENT ACCEPTED

Related Keywords

brom moxi ophthalmological compositions pharmaceutical